Research, published in JAMA Paediatrics, reports an association between screen time and an increase in symptoms of depression.    Dr Bernadka Dubicka, … read more

Treatment resistant depression effects a third of those with major depressive disorder. With limited treatment options available for these people, … read more

Research published in Lancet Psychiatry demonstrates that for the most commonly used second-generation antidepressants, the lower range of the licensed … read more

Research published in The BMJ provide evidence for the consideration of brain stimulation techniques as alternatives or supplements for adults … read more

Reactions to a meta-analysis published in JAMA Psychiatry which demonstrates a correlation between cannabis use and depression/anxiety in young people. … read more

Cannabis is the most commonly used recreational drug by teenagers worldwide and while there has been a lot of focus … read more

Reactions to a debate published in the BMJ on the efficacy of electroconvulsive therapy on people with depression. Prof Kamilla … read more

Updated National Institute for Health and Care Excellence (NICE) guidelines recommend digital Cognitive Behavioral Therapy (CBT) for mild depression in … read more

Research published in EClinicalMedicine highlights potential issues with greater social media use in relation to young people’s mental health. Prof Peter Fonagy, Head … read more

Whilst debate rages about treatments for depression, there is a large proportion of people for whom no treatments work at all. read more

Research published in JAMA Psychiatry demonstrates that testosterone treatment appears to be effective in reducing depressive symptoms in men. read more

Research, published in Molecular Psychiatry, shows that adhering to a healthy diet appears to confer some protection against depression. read more

A new study, published in JAMA, investigates the association between prescription medications and depression as a possible side effect. read more

Publishing in JAMA Psychiatry, researchers report results from a 12-month randomised clinical trial of estrogen plus progestin hormone therapy vs placebo for the prevention of depressive symptoms in non-depressed perimenopausal and early postmenopausal women.  read more

A new study, published in Scientific Reports, finds that patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a ‘reset’ of their brain activity.  read more

Publishing in JAMA Pediatrics, researchers conducted a systematic review and meta-analysis of studies that examined the association between autism spectrum disorders (ASD) and fetal exposure to antidepressants. read more

Researchers have published a review of the ethical considerations in off-label ketamine use for severe, treatment-resistant depression, in the Lancet Psychiatry. read more

Severe depression is the number one psychological disorder in the UK and yet 30% of patients do not respond to … read more

Antidepressants are a constant source of controversy. Concerns are raised that these drugs are not safe, that the side-effects are being overlooked, that they are being over-prescribed and are part of a trend of over-medicalisation. read more

A review of published evidence on the effect of antidepressants on suicidal behaviour and violence in healthy people is published in Journal of the Royal Society of Medicine with the authors reporting ‘antidepressants double the occurrence of events in adult healthy volunteers that can lead to suicide and violence.’ read more